DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "MediPoint: Spinal Non-fusion - Global Analysis and Market Forecasts" report to their offering.
The promise of spinal non-fusion technologies, while initially large during its infancy, has tapered somewhat with challenges developing in specific non-fusion device segments due to insufficient evidence of clinical efficacy. Currently, total disc replacement (TDR) represents the most frequently performed spinal non-fusion surgery. In particular, the safety and efficacy of cervical total disc replacement (C-TDR) has been established with a growing body of level-1 evidence that is compelling enough to no longer consider this surgery investigational.
This evidence is bolstered by experience with multiple devices, at multiple sites, in and out of the investigational setting and with short-, intermediate-, and long-term follow-up. At this point, C-TDR is widely seen as a viable alternative to anterior cervical discectomy and fusion surgeries in select indications.
The increasing availability of clinical efficacy data, together with the rising prevalence of degenerative spine diseases and the industry's aggressive efforts on physician training and DTC marketing, is propelling the market forward. In fact, the C-TDR market has already started to cannibalize a small portion of the spinal fusion market.
Key Questions Answered
- Future growth in the spinal non-fusion market lies in the C-TDR segment. How will the C-TDR segment drive the market revenue growth in the upcoming years? What are the current utilization patterns of one-level and double-level C-TDR procedures in different geographies?
- Most of the spine surgeons GlobalData interviewed indicated that the actual clinical effectiveness of lumbar TDR (L-TDR) is still unclear. Has this impacted the procedure volume growth of L-TDR procedures? How will this market evolve in the next five years?
- Moving forward, while IPD devices are expected to continue to generate traction in the spine community, the growth in the procedure number of IPD surgeries is likely to slow down. What are the current adoption trends of IPD devices?
- Market leading companies, such as DePuy Synthes and Medtronic, entered the non-fusion market initially through acquisitions. Since then, a league of small- to medium-sized companies have internally developed and marketed their artificial discs or other non-fusion technologies. Who are the major players in the spinal non-fusion market in different regions?
Key Topics Covered:
1 Tables & Figures
3 Treatment Modalities Overview
4 Competitive Assessment
5 Pipeline Products
6 Industry Overview
7 Market Drivers and Barriers
8 Unmet Needs and Market Opportunities
9 Current and Future Players
10 Market Outlook
- Alphatec Spine
- DePuy Synthes
- Globus Medical
- Paradigm Spine
- RTI Surgical
For more information visit http://www.researchandmarkets.com/research/gbt77t/medipoint_spinal